Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.
Nishikawa K, Asai T, Shigematsu H, Shimizu K, Kato H, Asano Y, Takashima S, Mekada E, Oku N, Minamino T.
Nishikawa K, et al. Among authors: shimizu k.
J Control Release. 2012 Jun 10;160(2):274-80. doi: 10.1016/j.jconrel.2011.10.010. Epub 2011 Oct 14.
J Control Release. 2012.
PMID: 22020380